Learn more on this topic: Defining the New Treatment Paradigm for Patients with Chronic Lymphocytic Leukemia

What do the NCCN Guidelines recommend for diagnostic workup and risk assessment in patients with newly diagnosed CLL?

Jeffrey Jones, MD, MPH
The James Cancer Hospital at The Ohio State University